Investment analysts at Cowen and Company assumed coverage on shares of Myokardia (NASDAQ:MYOK) in a research note issued to investors on Monday, The Fly reports. The brokerage set an “outperform” rating and a $24.00 price target on the stock. Cowen and Company’s target price would suggest a potential upside of 93.55% from the stock’s current […]
